Annual Accounts Receivable
$5.78 M
-$7.31 M-55.85%
December 31, 2023
Summary
- As of February 8, 2025, MXCT annual accounts receivable is $5.78 million, with the most recent change of -$7.31 million (-55.85%) on December 31, 2023.
- During the last 3 years, MXCT annual accounts receivable has risen by +$606.10 thousand (+11.72%).
- MXCT annual accounts receivable is now -55.85% below its all-time high of $13.09 million, reached on December 31, 2022.
Performance
MXCT Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Receivable
$4.56 M
-$21.00 K-0.46%
September 30, 2024
Summary
- As of February 8, 2025, MXCT quarterly accounts receivable is $4.56 million, with the most recent change of -$21.00 thousand (-0.46%) on September 30, 2024.
- Over the past year, MXCT quarterly accounts receivable has dropped by -$3.61 million (-44.16%).
- MXCT quarterly accounts receivable is now -65.16% below its all-time high of $13.09 million, reached on December 31, 2022.
Performance
MXCT Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
MXCT Accounts Receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -55.9% | -44.2% |
| 3 y3 years | +11.7% | -65.2% |
| 5 y5 years | +17.8% | -65.2% |
MXCT Accounts Receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -55.9% | at low | -65.2% | at low |
| 5 y | 5-year | -55.9% | +78.1% | -65.2% | +40.5% |
| alltime | all time | -55.9% | +829.4% | -65.2% | +269.9% |
MaxCyte Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $4.56 M(-0.5%) |
| Jun 2024 | - | $4.58 M(-23.5%) |
| Mar 2024 | - | $5.99 M(+3.7%) |
| Dec 2023 | $5.78 M(-55.8%) | $5.78 M(-29.2%) |
| Sep 2023 | - | $8.17 M(+7.3%) |
| Jun 2023 | - | $7.61 M(-18.1%) |
| Mar 2023 | - | $9.29 M(-29.0%) |
| Dec 2022 | $13.09 M(+90.3%) | $13.09 M(+59.4%) |
| Sep 2022 | - | $8.21 M(+3.8%) |
| Jun 2022 | - | $7.91 M(-26.4%) |
| Mar 2022 | - | $10.75 M(+56.3%) |
| Dec 2021 | $6.88 M(+33.0%) | $6.88 M(+15.4%) |
| Sep 2021 | - | $5.96 M(+4.2%) |
| Jun 2021 | - | $5.72 M(+10.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2020 | $5.17 M(+59.4%) | $5.17 M(+38.0%) |
| Jun 2020 | - | $3.75 M(+15.5%) |
| Dec 2019 | $3.24 M(-33.8%) | $3.24 M(+16.2%) |
| Jun 2019 | - | $2.79 M(-43.1%) |
| Dec 2018 | $4.90 M(+53.5%) | $4.90 M(+30.3%) |
| Jun 2018 | - | $3.76 M(+17.7%) |
| Dec 2017 | $3.20 M(+32.6%) | $3.20 M(-14.6%) |
| Jun 2017 | - | $3.74 M(+55.2%) |
| Dec 2016 | $2.41 M(+66.1%) | $2.41 M(+8.2%) |
| Jun 2016 | - | $2.23 M(+53.5%) |
| Dec 2015 | $1.45 M(+3.5%) | $1.45 M(+17.7%) |
| Jun 2015 | - | $1.23 M(-12.1%) |
| Dec 2014 | $1.40 M(+82.8%) | $1.40 M |
| Dec 2013 | $767.10 K(+23.4%) | - |
| Dec 2012 | $621.70 K | - |
FAQ
- What is MaxCyte annual accounts receivable?
- What is the all time high annual accounts receivable for MaxCyte?
- What is MaxCyte annual accounts receivable year-on-year change?
- What is MaxCyte quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for MaxCyte?
- What is MaxCyte quarterly accounts receivable year-on-year change?
What is MaxCyte annual accounts receivable?
The current annual accounts receivable of MXCT is $5.78 M
What is the all time high annual accounts receivable for MaxCyte?
MaxCyte all-time high annual accounts receivable is $13.09 M
What is MaxCyte annual accounts receivable year-on-year change?
Over the past year, MXCT annual accounts receivable has changed by -$7.31 M (-55.85%)
What is MaxCyte quarterly accounts receivable?
The current quarterly accounts receivable of MXCT is $4.56 M
What is the all time high quarterly accounts receivable for MaxCyte?
MaxCyte all-time high quarterly accounts receivable is $13.09 M
What is MaxCyte quarterly accounts receivable year-on-year change?
Over the past year, MXCT quarterly accounts receivable has changed by -$3.61 M (-44.16%)